Company:  ASSERTIO THERAPEUTICS, IN ... (ASRT)
Form Type:  SC 13G/A
Filing Date:  2/11/2019 
CIK:  0001005201 
Address:  100 SOUTH SAUNDERS RD
SUITE 300
 
City, State, Zip:  LAKE FOREST, Illinois 60045 
Telephone:  (224) 419-7106 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$3.30  
Change: 
0.025 (0.77%)  
Trade Time: 
01:56 PM EST  
Market Cap: 
$212.22M
Trade ASRT now with 

© 2019  
Description of Business
Assertio Therapeutics, Inc. (Assertio or the Company) is a specialty pharmaceutical company focused on neurology, orphan and specialty medicines. Our current specialty pharmaceutical business includes the following three products which we market in the United States (U.S.): * Gralise® (gabapentin), a once daily product for the management of postherpetic neuralgia (PHN), that we launched in October 2011. * CAMBIA® (diclofenac potassium for oral solution), a non-steroidal anti-inflammatory drug for the acute treatment of migraine attacks, that we acquired in December 2013. * Zipsor® (diclofenac potassium liquid filled capsules), a non-steroidal anti-inflammatory drug for the treatment of mild to moderate acute pain, that we acquired in June 2012.
Register and access this filing in:     
  FORM SC 13G/A